微信小陈
微信小章| 产品名称： | Streptomyces xinghaiensis Zhao et al. |
|---|---|
| 商品货号： | TS171934 |
| Deposited As： | Streptomyces fradiae (Waksman and Curtis) Waksman and Henrici |
| Strain Designations： | M48-E2724 NRRL B-2702 |
| Application： | Produces aspartate transaminase aspartate aminotransferase Produces macrocin Produces tylosin |
| Isolation： | Soil |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1877: ISP Medium 1 ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor： | Eli Lilly & Co. |
| References： | Lee SH, Lee KJ. Aspartate aminotransferase and tylosin biosynthesis in Streptomyces fradiae. Appl. Environ. Microbiol. 59: 822-827, 1993. PubMed: 8481008 Stark WM, et al. A fermentation study of the biosynthesis of tylosin in synthetic media. Ist. Super. Sanita Sci. Rep. 1: 340-354, 1961. Hamill RL, Stark WM. Macrocin, a new antibiotic, and lactenocin, an active degradation product. J. Antibiot. 17A: 133-139, 1964. |
| Cross References： | Nucleotide (GenBank) : M57437 Streptomyces fradiae tylosin resistance protein (tlrC) gene, complete cds. |